Edition:
United Kingdom

Kobayashi Pharmaceutical Co Ltd (4967.T)

4967.T on Tokyo Stock Exchange

6,970JPY
17 Nov 2017
Change (% chg)

¥130 (+1.90%)
Prev Close
¥6,840
Open
¥7,030
Day's High
¥7,030
Day's Low
¥6,920
Volume
248,500
Avg. Vol
173,044
52-wk High
¥7,090
52-wk Low
¥4,755

Latest Key Developments (Source: Significant Developments)

Kobayashi Pharmaceutical buys back 335,200 shares for 1.67 bln yen in September
Thursday, 6 Oct 2016 

Kobayashi Pharmaceutical Co Ltd <4967.T>: Says it repurchased 335,200 shares for 1.67 billion yen in total in September . Says this was part of the share repurchase plan announced on Aug. 25 .Says it accumulatively repurchased 458,400 shares for 2.25 billion yen in total as of Sep. 30.  Full Article

Kobayashi Pharmaceutical to merge U.S. firm Berlin Industries, Inc.
Thursday, 1 Sep 2016 

Kobayashi Pharmaceutical Co Ltd <4967.T>:Says it plans to merge the U.S.-based company Berlin Industries, Inc. and its wholly owned unit Perfecta Products, Inc. on Sep. 2.  Full Article

Kobayashi Pharmaceutical to repurchase shares at up to 8 bln yen
Thursday, 25 Aug 2016 

Kobayashi Pharmaceutical Co Ltd <4967.T>: Says it to repurchase up to 2 million shares of its common stock, representing a 2.49 percent stake .Say shares to be buys back at the price of up to 8 billion yen in total, from Aug. 26 to Dec. 22.  Full Article

R&I affirms KOBAYASHI PHARMACEUTICAL's rating at "A" and stable outlook
Wednesday, 20 Apr 2016 

KOBAYASHI PHARMACEUTICAL CO LTD:Rating and Investment Information, Inc. (R&I) has affirmed the rating on the company at "A".The rating outlook is stable.  Full Article

KOBAYASHI PHARMACEUTICAL revises consolidated full-year outlook for FY 2016
Wednesday, 20 Apr 2016 

KOBAYASHI PHARMACEUTICAL CO LTD:Says the company increased the consolidated full-year outlook for revenue to 137,000 million yen from 136,500 million yen for FY ended March 2016.Operating profit forecast decreased to 18,200 million yen from 19,200 million yen.Ordinary profit forecast decreased to 17,900 million yen from 18,900 million yen.Net profit forecast increased to 13,400 million yen from 13,300 million yen.Earnings per share increased to 329.10 yen from 326.64 yen.FY 2016 revenues of 136.30 billion yen, net income of 13.57 billion yen – Thomson Reuters I/B/E/S.Comments the low domestic sales and high overseas sales of household products manufacturing and sale business are the main reasons for the forecast.  Full Article

KOBAYASHI PHARMACEUTICAL completes share repurchase
Wednesday, 10 Feb 2016 

KOBAYASHI PHARMACEUTICAL CO LTD:Completes repurchase of 832,800 shares of its common stock, at the price of 7,999,996,969 yen in total, on Feb. 9.  Full Article

KOBAYASHI PHARMACEUTICAL to buy Monascus purpureus business
Monday, 1 Feb 2016 

KOBAYASHI PHARMACEUTICAL CO LTD:To buy Monascus purpureus business from an Osaka-based firm on May 31.  Full Article

KOBAYASHI PHARMACEUTICAL updates share repurchase status
Monday, 1 Feb 2016 

KOBAYASHI PHARMACEUTICAL CO LTD:Repurchases 363,600 shares for about 3,425,697,992 yen in total from Jan. 1 to Jan. 31.Says this was part of the share repurchase plan announced on Oct. 29, 2015.Says accumulatively repurchased 762,000 shares for 7,291,930,973 yen in total as of Jan. 31.  Full Article

KOBAYASHI PHARMACEUTICAL to change fiscal year end date
Monday, 25 Jan 2016 

KOBAYASHI PHARMACEUTICAL CO LTD:To change its fiscal year end date to Dec. 31 each year from March 31 each year.Its 99th fiscal year will be from April 1, 2016 to Dec. 31, 2016.  Full Article

BRIEF-Kobayashi Pharmaceutical says private placement of treasury stock

* Says it will distribute 850,000 shares of its treasury common stock at 1 yen per share through private placement to The Master Trust Bank of Japan, Ltd.